Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.70 +0.01 (+0.11%)
As of: Sep 30, 2026 · 11:43 AM EDT

Oramed Pharmaceuticals (ORMP) Total Non-Current Liabilities (2011 - 2026)

Updated

Oramed Pharmaceuticals' Total Non-Current Liabilities was $41.44 million in Q2 2026, up 840.1% from $4.41 million a year earlier and up 107.1% from the prior quarter.

Analysis

Oramed Pharmaceuticals (ORMP) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at Oramed Pharmaceuticals came in at $12.03 million, up 183.4% from FY2024.

  • Total Non-Current Liabilities shows a five-year compound annual growth rate of 10.8% (FY2020 to FY2025).
  • In earlier years, Total Non-Current Liabilities was $4.25 million in FY2024 (-4.5%), $4.44 million in FY2023 (-6.2%), $4.74 million in FY2022 (+23.4%) and $3.84 million in FY2021.
  • The Q2 2026 figure marks the highest quarterly Total Non-Current Liabilities in data going back to Q4 2011.
  • Compared with a year earlier, Total Non-Current Liabilities has increased for five straight quarters, with growth averaging 247.0% over the last eight quarters.
  • The best year-over-year quarter for Total Non-Current Liabilities over five years was Q2 2026 (growth of 840.1%); the worst was Q1 2025 (a decline of 50.8%).
  • Per Business Quant data, ORMP's Total Non-Current Liabilities in the three quarters before Q2 2026 was $20.01 million (Q1 2026), $12.03 million (Q4 2025) and $12.04 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Oramed Pharmaceuticals 196.24 Mn 196.24 Mn - 41.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41.44 Mn
Mar 31, 2026 20.01 Mn
Dec 31, 2025 12.03 Mn
Sep 30, 2025 12.04 Mn
Jun 30, 2025 4.41 Mn
Mar 31, 2025 2.15 Mn
Dec 31, 2024 4.25 Mn
Sep 30, 2024 4.29 Mn
Jun 30, 2024 4.34 Mn
Mar 31, 2024 4.38 Mn
Dec 31, 2023 4.44 Mn
Sep 30, 2023 4.49 Mn
Jun 30, 2023 4.59 Mn
Mar 31, 2023 4.66 Mn
Dec 31, 2022 4.74 Mn
Sep 30, 2022 4.77 Mn
Jun 30, 2022 2.84 Mn
Mar 31, 2022 3.68 Mn
Nov 30, 2021 4.10 Mn
Aug 31, 2021 4.80 Mn
API Access

Oramed Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ORMP&period=max&api_key=YOUR_API_KEY